Semaglutide

Product Information

Semaglutide is a long-acting synthetic GLP-1 analog (C187H291N45O59, 4113.641 g/mol) that mimics natural incretin hormones with extended duration properties. This modified peptide activates GLP-1 receptors, triggering glucose-dependent insulin release while suppressing glucagon secretion and delaying gastric emptying. Research studies demonstrate its influence on central appetite control mechanisms and metabolic pathway regulation. The compound's once-weekly dosing potential in laboratory applications enables extended metabolic observations. Research focus areas include glycemic control mechanisms, weight management pathways, cardiovascular health investigations, metabolic syndrome studies, liver health research, and kidney function analysis. Semaglutide's comprehensive metabolic effects across multiple organ systems make it an exceptional research tool for understanding integrated metabolic control. Laboratory findings provide insights into incretin biology and metabolic homeostasis. For laboratory research purposes only.